• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

New diabetes software from Klue features mealtime insulin reminders

November 2, 2018 By Sarah Faulkner

Klue logoDigital health company Klue announced this week that its latest AI-driven software is a module designed for people with Type I diabetes.

The technology features autonomous meal detection capabilities and provides mealtime medication reminders to users, according to the San Francisco, Calif.-based company.

The module, which works with hardware like the Apple Watch, also provides automated text messaging for caregivers. Klue noted that its software can be integrated into third-party apps.

People with Type I diabetes can access the new bolus reminder module in the Klue Health App for the Apple Watch ahead of its launch, according to Klue, by signing up for trial spots.

“We are here to help people live healthier and happier lives. We believe that the future of healthcare delivery will thrive on personal, in-the-moment interactions centered around times of high impact,” Klue’s founder & CEO, Katelijn Vleugels, said in prepared remarks. “The introduction of a reminder module for mealtime insulin administration is another important step in the realization of that vision.”

“I am excited about the potential of Klue’s early meal detection capabilities to advance Type 1 diabetes research and reduce the burden of diabetes,” Dr. Marc Breton, professor at the UVA Center for Diabetes Technology, added. “Missed pre-meal insulin boluses are a leading contributor to poor glycemic control and Klue’s real-time detection could be beneficial to many people with type 1 diabetes. I am most excited about the prospect of using Klue’s technology within a fully autonomous closed-loop artificial pancreas system. Automated real-time information of a patient’s eating behavior, coupled with novel control algorithms, may very well enable a true ‘set and forget’ closed loop insulin delivery system.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Featured, mHealth (Mobile Health), Pharmaceuticals, Technology Tagged With: klue

IN CASE YOU MISSED IT

  • Lyra Therapeutics appoints new chief medical officer
  • FDA lifts hold on Vertex’s insulin-producing cell therapy for diabetes
  • Retractable Technologies declares dividends
  • Teva appoints former Vertex exec as new head of R&D, CMO
  • West Pharmaceutical Services debuts new needle syringe system

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS